Grifols S.A. Cl B | Ownership
Companies that own Grifols S.A. Cl B
Capital Research & Management Co. (Global Investors)
19,251,382
7.36%
0
0.08%
06/30/2018
Capital Research & Management Co. (World Investors)
13,488,766
5.16%
0
0.04%
06/30/2018
The Vanguard Group, Inc.
5,505,671
2.11%
5,623
0%
07/31/2018
Fidelity Management & Research Co.
3,610,293
1.38%
-683
0.01%
07/31/2018
Capital International Ltd.
3,304,730
1.26%
0
0.86%
06/30/2018
Santander Asset Management SA SGIIC
3,118,979
1.19%
426,958
0.71%
03/31/2018
BlackRock Investment Management (UK) Ltd.
2,224,418
0.85%
236,380
0.01%
06/30/2018
Oddo BHF Asset Management SAS
1,736,186
0.66%
352,078
0.34%
04/30/2018
Schroder Investment Management Ltd.
1,239,576
0.47%
22,803
0.02%
05/31/2018
GLG Partners UK Ltd.
954,222
0.37%
0
0.28%
07/31/2018
| Address |
Avinguda de la Generalitat, 152-158
Barcelona Catalonia 08174
Spain
|
|
Employees
|
- |
| Website |
http://www.grifols.com |
| Updated |
07/08/2019 |
| Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through the following segments: Bioscience, Hospital, Diagnostic and Raw Materials. |
